H.R. 7352: To amend the Public Health Service Act to establish a program to develop innovative antimicrobial drugs targeting the most challenging pathogens and most threatening infections, and for other purposes.
Sponsors
9 bill sponsors
-
TrackEarl L. "Buddy" Carter
Sponsor
-
TrackMike Carey
Co-Sponsor
-
TrackBrian K. Fitzpatrick
Co-Sponsor
-
TrackNicholas A. Langworthy
Co-Sponsor
-
TrackMike Levin
Co-Sponsor
-
TrackScott H. Peters
Co-Sponsor
-
TrackDeborah K. Ross
Co-Sponsor
-
TrackTerri A. Sewell
Co-Sponsor
-
TrackChristopher H. Smith
Co-Sponsor
Actions
2 actions
| Date | Action |
|---|---|
| Feb. 04, 2026 | Introduced in House |
| Feb. 04, 2026 | Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.